Belgium · Investor

Gimv

Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietPrivate equity

SeedSeries ASeries BConsumerHealthcareSmart Industries

Cheques on record
0%of best year0cheques in 12 months, 104 on record
Since the last cheque2523days00hrs00min00sec
Median round$42MRounds led3 of 104Sole investor11 roundsExits24 from the portfolioMostly inBelgium, 40%
Pitch Gimv

Gimv highlights

  1. 01

    104 rounds on record

  2. 02

    Mostly Series B and Venture: 59% of its rounds

  3. 03

    Sole investor in 11 rounds, median $6.3M

  4. 04

    24 exits from the portfolio

What they do

Gimv is a European investment company, listed on Euronext Brussels. As a recognized market leader, we partner with entrepreneurial and innovative companies in 4 forward-looking investment areas.From their own website
Type
Private equity (from a list, unverified)
Cheque size
From $5.0M as they say
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
ConsumerHealthcareSmart Industries
Based in
Antwerp, Belgium
Cold pitches
Not accepted

The record

Every round we can evidence, newest first104 appearances

  1. 2019

    3 rounds

  2. Dec
    ImCheck TherapeuticsSeries B · FR · FinSMEs$53MWith 9 others
  3. Sept
    iSTAR Medical SASeries C · BE · Capricorn Partners$44MLed
  4. Jul
    AgroSavfeSeries C · BE · EU-Startups$39MLed
  5. 2018

    1 round

  6. Nov
    Camel-IDSSeries A · BE · Healthcap$42MLed
  7. 2017

    1 round

  8. Mar
    AgrosavfeSeries B · BE · FinSMEs$12MWith 7 others
  9. 2015

    4 rounds

  10. Sept
    Biom'UpSeries C · FR$35MWith 2 others
  11. Aug
    JenaValve TechnologySeries C · DE$27MWith 7 others
  12. May
    ItinerisBE$10MWith 2 others
  13. Jan
    TeadsSeries C · US$14MWith 4 others
  14. 2014

    2 rounds

  15. Sept
    thinkstepSeries B · DE$13MWith 1 other
  16. Apr
    JenaValve TechnologySeries C · DE$10MWith 8 others
  17. 2013

    8 rounds

  18. Dec
    CovagenSeries B · CH · pehub.com$47MWith 7 others
  19. Dec
    EuroceptNL · finsmes.comUndisclosedSole investor
  20. Oct
    NovoPolymersBE · novopolymers.comUndisclosedWith 3 others
  21. Jul
    JenaValve TechnologySeries C · DE · finsmes.com$63MWith 7 others
  22. Jun
    ComplixSeries B · BE · prnewswire.com$15MWith 7 others
  23. Jun
    Marco VascoSeries A · FR · finsmes.com$19MWith 1 other
  24. Feb
    MultiplicomVenture · BE · finsmes.com$7.4MWith 2 others
  25. Jan
    AgroSavfeVenture · BE · finsmes.com$6.6MWith 1 other
  26. 2012

    11 rounds

  27. Nov
    EndosenseSeries C · CH · finsmes.com$40MWith 7 others
  28. Nov
    Ambit BiosciencesVenture · US · phx.corporate-ir.net$50MWith 8 others
  29. Sept
    GOVECSVenture · DE · finsmes.com$13MWith 2 others
  30. Aug
    MoveaSeries C · FR · finsmes.com$8.0MWith 2 others
  31. Jul
    ARS Traffic & Transport TechnologyNL · finsmes.comUndisclosedSole investor
  32. May
    ProsonixSeries B · GB · finsmes.com$27MWith 5 others
  33. Mar
    NovoPolymersVenture · BE · finsmes.com$7.1MWith 1 other
  34. Mar
    GreenWattVenture · BE · finsmes.com$7.9MWith 3 others
  35. Feb
    Oldelft UltrasoundNL · finsmes.comUndisclosedSole investor
  36. Jan
    ProsensaVenture · NL · reuters.com$30MWith 6 others
  37. Jan
    PronotaSeries C · BE · pronota.com$4.8MWith 6 others
  38. 2011

    10 rounds

  39. Oct
    TrustTeamBE · finsmes.comUndisclosedSole investor
  40. Sept
    ActivePathSeries B · US · techcrunch.com$10MWith 2 others
  41. Sept
    SeedcampVenture · GB · techcrunch.com$2.8MWith 6 others
  42. Aug
    EbuzzingSeries B · GB · techcrunch.com$25MSole investor
  43. Aug
    TeadsSeries B · FR$25MWith 4 others
  44. Aug
    StudiekringNL · finsmes.comUndisclosedSole investor
  45. Aug
    XL VideoVenture · BE · finsmes.com$27MSole investor
  46. Jun
    Ambit BiosciencesSeries D · US · phx.corporate-ir.net$30MWith 9 others
  47. Apr
    MultiplicomVenture · BE · trivano.com$2.9MWith 1 other
  48. Feb
    NovoPolymersSeries B · BE · novopolymers.com$5.8MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 64 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

5+funds on filenumbered funds in its name

Exits from the portfolio

Companies it backed that were later bought or listed24 in all

ProsonixBought by CircassiaUndisclosedMay 2015
ActoGeniXBought by Intrexon Corporation$60MFeb 2015
ProsensaBought by BioMarin Pharmaceutical$840MNov 2014
Clear2PayBought by C&E HoldingsUndisclosedOct 2014
Ambit BiosciencesBought by Daiichi Sankyo$410MSept 2014
CovagenBought by CilagUndisclosedAug 2014
MoveaBought by InvenSenseUndisclosedJul 2014
EndosenseBought by St. Jude Medical$170MAug 2013
ProsensaListed$78MJun 2013
LiquavistaBought by AmazonUndisclosedMay 2013
VirtenSysBought by Micron TechnologyUndisclosedJan 2012
PsytechnicsBought by NetScout SystemsUndisclosedMar 2011
PlexxikonBought by Daiichi Sankyo$935MFeb 2011
LiquavistaBought by Samsung ElectronicsUndisclosedJan 2011
MovetisBought by Shire$565MAug 2010
CoreOpticsBought by Cisco$99MMay 2010
CoWareBought by SynopsysUndisclosedFeb 2010
Fovea PharmaceuticalsBought by Sanofi AventisUndisclosedOct 2009
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
AblynxListedUndisclosedNov 2007

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Gimv. A count of rooms they were both in, not a relationship either has claimed.

Alta PartnersVC firm12rounds togetherSofinnova PartnersVC firm12rounds togetherEQT life sciencePrivate equity7rounds togetherForward VenturesAccelerator7rounds togetherVIBVC firm7rounds togetherIdinvest PartnersPrivate equity6rounds togetherNIF VenturesGrowth equity6rounds togetherOrbiMedPrivate equity6rounds togetherQuest for GrowthVC firm6rounds togetherBaekeland FundsVC firm5rounds togetherBiotech Fund FlandersVC firm5rounds togetherEdmond de Rothschild Venture CapitalGrowth equity5rounds together

Recently backed

The latest companies Gimv put money into.

ImCheck Therapeutics$53M · Dec 2019

Quick answers about Gimv

What does Gimv invest in?

Gimv invests most often at Series B and Venture (59% of the rounds on record), in sectors such as Consumer, Healthcare and Smart Industries.

How active is Gimv?

104 investments on record, 0 of them in the last 12 months, and it led 3. The most recent was in Dec 2019.

What has Gimv invested in recently?

Its most recent investments on record: ImCheck Therapeutics (Series B, Dec 2019), iSTAR Medical SA (Series C, Sept 2019) and AgroSavfe (Series C, Jul 2019).

How big are Gimv's cheques?

The median round it joins is $42M.

Does Gimv lead rounds?

Sometimes: it led 3 of its 104 investments on record (3%).

Where does Gimv invest?

Most of the companies it backs are in Belgium (40%), France (13%) and Germany (13%).

Is Gimv investing now?

No investments in the last 12 months; the latest was in Dec 2019.

Who does Gimv invest alongside?

Most often Alta Partners (12 rounds together), Sofinnova Partners (12 rounds together) and EQT life science (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it